Switching between eltrombopag and recombinant human thrombopoietin in patients with immune thrombocytopenia: an observational study

BACKGROUND: Recombinant human thrombopoietin (rh-TPO) and eltrombopag are two distinct TPO receptor agonists (TPO-RAs) with different mechanisms. During the pandemic, when immunosuppressive medications are controversial, switching to another TPO-RA may be worth exploring in patients who do not benef...

Descripción completa

Detalles Bibliográficos
Autores principales: Cai, Xuan, Fu, Haixia, Zhao, Xiangyu, Lu, Jin, Jiang, Qian, Chang, Yingjun, Huang, Xiaojun, Zhang, Xiaohui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9771238/
https://www.ncbi.nlm.nih.gov/pubmed/36535011
http://dx.doi.org/10.1097/CM9.0000000000002346

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9771238/
https://www.ncbi.nlm.nih.gov/pubmed/36535011
http://dx.doi.org/10.1097/CM9.0000000000002346

Ejemplares similares